Speciality: Oncology
Description:
Dr. Sushant Mittal kicked off the insightful session titled "CNS Clarity from Day One: Rethinking Early Diagnostic Strategies", joined by esteemed panelists Dr. Tarachand Gupta and Dr. Randeep Singh. The discussion opened with a strong emphasis on the clinical importance of early evaluation for central nervous system (CNS) involvement, especially in complex or aggressive disease presentations. Dr. Mittal highlighted how delays in CNS assessment can result in mismanagement or missed therapeutic windows, setting the tone for a thought-provoking exchange. Dr. Gupta and Dr. Singh added their expertise from neurology and oncology perspectives, offering valuable multidisciplinary insights.
The session explored how CNS evaluation at the time of initial diagnosis is gaining traction in clinical protocols. With advancements in neuroimaging, cerebrospinal fluid analysis, and molecular biomarkers, early detection of CNS disease has become more achievable and actionable. The panel discussed real-world challenges in integrating these strategies, including resource constraints and variability in presentation. Emphasis was placed on identifying high-risk patients early - particularly in oncology and infectious disease contexts - where CNS involvement can significantly affect prognosis and treatment pathways. The conversation also touched on the need for standardized screening protocols and decision-making frameworks that support clinicians across specialties.
Thank you to all who joined this informative session. Your engagement and curiosity continue to drive these meaningful conversations forward. Special thanks to Dr. Sushant Mittal, Dr. Tarachand Gupta, and Dr. Randeep Singh for sharing their expertise. Keep following us for more sessions focused on innovation, interdisciplinary practice, and cutting-edge strategies in healthcare. Together, we’re reshaping how diseases are diagnosed and managed - starting from day one.
See More Webinars @ Hidoc Webinars
1.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
2.
Telemedicine Not Reaching Rural Psychiatric Patients
3.
Have the Harms of Lung Cancer Screening Been Exaggerated?
4.
Survivors of childhood brain cancer are more likely to be held back in school
5.
Why breast cancer survivors don't take their medicine, and what can be done about it.
1.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
2.
MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps
3.
HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer
4.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
5.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation